எலும்பியல் ஆராய்ச்சி சமூகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from எலும்பியல் ஆராய்ச்சி சமூகம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In எலும்பியல் ஆராய்ச்சி சமூகம் Today - Breaking & Trending Today

Dietary Supplement and Personal Care Product Regulatory and Litigation Highlights – March 2021 | Kelley Drye & Warren LLP


To embed, copy and paste the code into your website or blog:
Welcome to our curated selection of highlights of regulatory and litigation developments in the dietary supplement and personal care product industries for March 2021.  In case you were wondering what pain relief, teeth whitening, and CBD have in common (and, who wasn’t?) it seems that one year into the pandemic, these are the advertising battles being fought in multiple forums. Read on…
National Advertising Division
NAD addressed some unique superiority and comparative claims in the OTC drug space in finding that Hisamitsu America, Inc., supported its duration claims that Salonpas Pain Relief Patch Large “works for up to 12 hours” and “provides relief for up to 12 hours.” However, NAD found that comparative claims such as “All OTC pain relievers, including Voltaren, have one thing in common. None are proven stronger or more effective against pain than Salonpas Pain Relief Patch Large” and ....

New York , United States , Day Energy Greens , Elanco Animal Health Inc , Colgate Palmolive , Palmolive Company , Naturmed Inc , Reckitt Bensicker , National Advertising Division , Infinite Product Co , Orthopaedic Research Society , Hisamitsu America Inc , Llccd Cal , Hisamitsu America , Salonpas Pain Relief Patch Large , Salonpas Pain Relief Patch , Colgate Palmolive Company , Optic White Renewal Toothpaste , Goli Nutrition , Cosmetics Act , Eastern District , Bactolac Pharmaceutical , Day Energy , Free Advanced , Look Good Feel , Southern District ,

Conformis, Inc.: Clinical Study: Patient-Specific Total Knee Replacement with Conformis Technology Is More Cost-Effective Than with Leading Off-the-Shelf Implants


(2)
Independent, retrospective review of 2016-2019 surgeon data by University of Washington researchers demonstrates that Conformis iTotal knee replacement implants enable expedited surgical time and reduce length of hospital stay.
BILLERICA, Mass., March 17, 2021 (GLOBE NEWSWIRE) Conformis, Inc. (NASDAQ:CFMS) announced today that an independent, retrospective review of hospital data has concluded that Conformis iTotal knee replacement technology is more cost-effective than leading traditional, off-the-shelf implants. Importantly, this study was independently performed with no sponsorship or funding from Conformis.
The new abstract was presented by authors at the Orthopaedic Research Society 2021 Annual Meeting (ORS 2021 Annual Meeting), held in February 2021:
Custom-designed total knee arthroplasty is cost-effective in comparison to a standard implant (https://www.ors.org/Transactions/67/980.pdf), Navin Fernando MD, Ann Chancellor CCRC, Paul Manner MD, Univers ....

United States , Richardg Buch , Mark Augusti , Jason Davis , Navin Fernando , Robertw Eberle , Rylie Buch , Exchange Commission , University Of Washington , Proceedings Of Orthopaedic Research Society , Orthopaedic Research Society , Department Of Orthopaedics , Conformis Inc , Mann Chancellor , Paul Manner , Knee Arthritis Professor , Sports Medicine , Zimmer Persona , Stryker Triathlon , Chief Executive Officer , Total System , Economic Value , Custom Implants , Implant Design Affect Hospital Metrics , Fast Track Protocol , Adverse Event Rates ,

University Scholar Lecture Series – Gary S. Stein, Ph.D.


The Cancer-Compromised Genome
The Graduate College is pleased to present the Teams Live Event: The Cancer-Compromised Genome, a lecture by University Scholar Gary S. Stein, Ph.D. on Monday, March 22, 2021 at 4:30 pm. The event can be joined at http://go.uvm.edu/universityscholars.
A mechanistic and clinical challenge is understanding and treating cancer as a disease of compromised cellular and molecular organization. Cancer onset and progression are functionally associated with aberrant genetic (DNA-encoded) and epigenetic (non DNA-encoded) mechanisms that influence the transmission and retention of regulatory information during cell division. Cancer cells must sustain their compromised genome structure (deletions, amplifications, rearrangements), epigenetic status and function otherwise cancer would be cured by cell division. Each regulatory component of gene expression is linked to architectural organization of regulatory machinery in the cell nucleus. Fidelity of ....

United States , University Of Massachusetts Medical School , University Of Massachusetts , Universidad Andr , Gary Stein , Janet Stein , University Of Massachusetts Cancer Center , Pakistan Academy Of Sciences , Massachusetts Center , Department Of Biochemistry , American Association For The Advancement Of Science , Brown University , Orthopedic Research Society , Larner College Of Medicine , University Scholar Garys Stein , Cancer Center , Vermont Cancer Coalition , American Academy Of Orthopedic Surgeons , Translational Research Network , Mineral Research , American Society Of Bone , Graduate College , Teams Live Event , Cancer Compromised Genome , University Scholar Gary , Jane Lian ,